Septerna is poised for a pivotal catalyst with upcoming Phase 1 data for SEP-631, targeting mast cell-driven diseases via ...

In modern information technology, the efficient and dynamic manipulation of these light "codes" is key to achieving ...

Phase 1b translational data demonstrate localized ileocolonic target engagement, suppression of inflammatory and fibrotic gene programs, and ...

Announcing a new publication from Opto-Electronic Advances; DOI 10.29026/oea.2026.250177 .Light, as a core carrier of information, possesses multiple ...

Announcing a new publication from Opto-Electronic Advances; DOI 10.29026/oea.2026.250229 .Programmable metasurface (PM), also termed as ...

Many cutting-edge technologies, ranging from augmented reality (AR) and virtual reality (VR) to LiDAR (light detection and ranging) systems, rely on components that enable the precise control of light ...

Immunocore reports fourth quarter and full year 2025 financial results and provides a business update KIMMTRAK (tebentafusp-tebn) Q4 net sales ...

Helus Pharma (NASDAQ: HELP) is a clinical-stage pharmaceutical company developing treatments for depression and anxiety. Its ...

Polyphenol-rich berries may improve insulin sensitivity, regulate leptin, and modestly boost memory while influencing amyloid and tau pathways in obesity-related decline.

Bloom Science, Inc., a clinical-stage biotech company focused on the development of novel therapies for metabolic and neurological disorders, today announced that the first patient has been dosed in ...

DelveInsight forecasts a rise in the drug-resistant epilepsy market from 2025 to 2034, driven by higher prevalence, improved diagnosis, treatment advances, aging demographics, increased awareness, and ...

CJ BIO announced the publication of clinical research findings on its postbiotic ingredient, BiomeNrichtm POST SZ075, in an international peer-reviewed journal. The study strengthens the scientific ...